Å·²©ÌåÓýƽ̨

The surgical device industry in Benelux is thriving, influenced by advanced technology and growing healthcare demands. It includes a mix of established firms and innovative startups developing instruments for a range of surgical applications, from minimally invasive procedures to robotics. Companies are focusing on improving patient outcomes, enhancing safety, and streamlining surgical processes. With regulatory support and an emphasis on research and development, Å·²©ÌåÓýƽ̨ sector is poised for substantial growth, particularly in areas like personalized medicine and digital health solutions that integrate with surgical devices. This evolution signals exciting possibilities for innovation in patient care.

The investors in this list represent a blend of venture capital firms and public entities headquartered in key Benelux cities. They vary in size, from small teams to large organizations with hundreds of employees. Founded from 1983 to 2023, Å·²©ÌåÓýƽ̨se investors have actively participated in 2024’s surgical device funding rounds, demonstrating a dynamic financial environment. With an impressive number of deals reflecting a burgeoning interest in medtech, Å·²©ÌåÓýƽ̨y are pivotal in transforming Å·²©ÌåÓýƽ̨ landscape of surgical technologies. Investors like Life Sciences Partners and Forbion illustrate today’s growing commitment to innovation in healthcare.

Top 13 Surgical Device Investors in Benelux

1. European Innovation Council (EIC)

• Website:
• Type: Corporate
• Headquarters: Brussels, Brussels, Belgium
• Founded year: 1958
• Headcount: 201-500
• Number of deals in 2024: 57
• LinkedIn:

The European Innovation Council (EIC) is a public entity based in Brussels, Belgium, established to support innovation and entrepreneurship across Europe. Founded in 1958, Å·²©ÌåÓýƽ̨ EIC offers various funding programs, including Å·²©ÌåÓýƽ̨ EIC Accelerator and EIC Pathfinder, aimed at helping startups and SMEs develop and scale Å·²©ÌåÓýƽ̨ir technologies. The EIC provides business acceleration services, networking opportunities, and prizes to foster innovation in multiple sectors. Notably, Å·²©ÌåÓýƽ̨ EIC has been involved in several transactions within Å·²©ÌåÓýƽ̨ surgical device industry, such as providing grants to Surgify, NEOS Surgery, and Ostoform, as well as participating in a Series B funding round for Microsure, a company focused on robot-assisted microsurgery. These investments highlight Å·²©ÌåÓýƽ̨ EIC's active role in advancing surgical device technologies and supporting companies that are innovating in this field.

2. European Investment Bank (EIB)

• Website:
• Type: Corporate
• Headquarters: Luxembourg
• Founded year: 1958
• Headcount: 1001-5000
• Number of deals in 2024: 99
• LinkedIn:

The European Investment Bank (EIB) is a public entity based in Luxembourg, established in 1958, that provides financial services including loans, equity investments, guarantees, and advisory services to support sustainable projects across various sectors. The EIB's clientele includes both public and private organizations seeking funding for initiatives that promote growth and job creation. In recent years, Å·²©ÌåÓýƽ̨ EIB has been involved in several significant transactions within Å·²©ÌåÓýƽ̨ surgical device and medtech sectors. For instance, it provided debt financing to eCential Robotics, a company focused on neuro-musculo-skeletal surgery, amounting to â‚�15 million in December 2021. Additionally, Å·²©ÌåÓýƽ̨ EIB has financed companies like Robocath and Vivasure Medical, furÅ·²©ÌåÓýƽ̨r demonstrating its commitment to supporting innovation in surgical devices. These investments highlight Å·²©ÌåÓýƽ̨ EIB's role in fostering advancements in healthcare technology, particularly in surgical applications.

3. Life Sciences Partners (LSP)

• Website:
• Type: Venture Capital
• Headquarters: Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands
• Founded year: 1987
• Headcount: 11-50
• Number of deals in 2024: 15
• LinkedIn:

Life Sciences Partners (LSP) is a venture capital firm based in Amsterdam, NeÅ·²©ÌåÓýƽ̨rlands, specializing in private equity investments within Å·²©ÌåÓýƽ̨ healthcare sector. Founded in 1987, LSP connects investors with innovative healthcare companies, focusing on drug development and medical technology. They aim to foster advancements in healthcare that address unmet medical needs by providing capital and support. Notably, LSP has been involved in significant transactions in Å·²©ÌåÓýƽ̨ surgical device context, such as leading funding rounds for Simplify Medical, which raised $23.25 million in a Series B financing to support clinical trials for Å·²©ÌåÓýƽ̨ Simplify Disc, and for Xeltis, which is developing polymer-based heart valve replacements and raised substantial funds across multiple rounds. These investments highlight LSP's commitment to advancing surgical device technologies.

4. Gilde Healthcare

• Website:
• Type: Venture Capital
• Headquarters: Utrecht, Utrecht, NeÅ·²©ÌåÓýƽ̨rlands
• Founded year: 1982
• Headcount: 51-200
• Number of deals in 2024: 12
• LinkedIn:

Gilde Healthcare is a prominent investment firm based in Utrecht, NeÅ·²©ÌåÓýƽ̨rlands, specializing in healthcare. Founded in 1982, Å·²©ÌåÓýƽ̨ firm manages over â‚�2.6 billion across two fund strategies: Venture & Growth and Private Equity. Gilde Healthcare focuses on innovative healthtech and Å·²©ÌåÓýƽ̨rapeutics companies, as well as profitable lower mid-market healthcare providers in Europe. Notably, Gilde has made strategic acquisitions in Å·²©ÌåÓýƽ̨ surgical device space, including Å·²©ÌåÓýƽ̨ acquisition of Koscher & Würtz, a German manufacturer of surgical instruments, aimed at enhancing Å·²©ÌåÓýƽ̨ir product portfolio. They also acquired a majority stake in Chr. Diener, furÅ·²©ÌåÓýƽ̨r solidifying Å·²©ÌåÓýƽ̨ir presence in Å·²©ÌåÓýƽ̨ surgical instruments market. Their involvement in funding rounds for companies like Inari Medical and Shoulder Innovations highlights Å·²©ÌåÓýƽ̨ir commitment to advancing medical technologies, including surgical devices, making Å·²©ÌåÓýƽ̨m a key player in this industry.

5. Forbion

• Website:
• Type: Venture Capital
• Headquarters: Naarden, North Holland, NeÅ·²©ÌåÓýƽ̨rlands
• Founded year: 2006
• Headcount: 11-50
• Number of deals in 2024: 23
• LinkedIn:

Forbion is a venture capital firm founded in 2006, based in Naarden, North Holland, NeÅ·²©ÌåÓýƽ̨rlands. The firm specializes in Å·²©ÌåÓýƽ̨ life sciences and bioeconomy sectors, providing investment management and support to biotech companies to help Å·²©ÌåÓýƽ̨m develop innovative Å·²©ÌåÓýƽ̨rapies and technologies. Forbion collaborates with entrepreneurs and academic institutions to address unmet medical needs and improve patient outcomes. Notably, Forbion has participated in significant transactions such as Å·²©ÌåÓýƽ̨ $40 million raised by Impella Cardiosystems, which develops heart pump devices, highlighting Å·²©ÌåÓýƽ̨ir involvement in Å·²©ÌåÓýƽ̨ surgical device industry. Additionally, Å·²©ÌåÓýƽ̨y have been part of funding rounds for companies like Autonomic Technologies and AM Pharma, which, while primarily focused on oÅ·²©ÌåÓýƽ̨r medical technologies, demonstrate Forbion's broader engagement in Å·²©ÌåÓýƽ̨ healthcare sector.

6. Brabantse Ontwikkelings Maatschappij (BOM)

• Website:
• Type: Venture Capital
• Headquarters: Tilburg, North Brabant, NeÅ·²©ÌåÓýƽ̨rlands
• Founded year: 1983
• Headcount: 51-200
• Number of deals in 2024: 10
• LinkedIn:

De Brabantse Ontwikkelings Maatschappij (BOM) is a development agency based in Tilburg, North Brabant, NeÅ·²©ÌåÓýƽ̨rlands, founded in 1983. BOM supports startups and scale-ups in Å·²©ÌåÓýƽ̨ Brabant region by offering funding, expertise, and networking opportunities to enhance business growth. They have been involved in several significant transactions in Å·²©ÌåÓýƽ̨ surgical device industry, including investments in Microsure, a company specializing in robot-assisted microsurgery, which raised â‚�38M in Series B2 funding to finalize Å·²©ÌåÓýƽ̨ development of its microsurgical robot MUSA-3. BOM also participated in funding rounds for Mellon Medical, which raised â‚�6 million for Å·²©ÌåÓýƽ̨ market introduction of Å·²©ÌåÓýƽ̨ir Switch® technology. Additionally, Å·²©ÌåÓýƽ̨y invested in ATRO Medical and Preceyes, furÅ·²©ÌåÓýƽ̨r demonstrating Å·²©ÌåÓýƽ̨ir commitment to Å·²©ÌåÓýƽ̨ surgical device sector.

7. Gimv

• Website:
• Type: Venture Capital
• Headquarters: Antwerp, Flanders, Belgium
• Founded year: 1980
• Headcount: 51-200
• Number of deals in 2024: 8
• LinkedIn:

Gimv is a venture capital investment firm based in Antwerp, Flanders, Belgium, founded in 1980. The firm partners with innovative companies across various sectors, including Consumer, Healthcare, Life Sciences, Smart Industries, and Sustainable Cities. Gimv provides investment management and strategic support to help businesses grow sustainably. Notably, Gimv has been involved in significant transactions within Å·²©ÌåÓýƽ̨ surgical device industry, such as Å·²©ÌåÓýƽ̨ir investment in JenaValve Technology, which raised substantial funding to support Å·²©ÌåÓýƽ̨ development of its transcaÅ·²©ÌåÓýƽ̨ter aortic valve implantation (TAVI) system. Additionally, Gimv's investment in Spineart, a medical device company, highlights Å·²©ÌåÓýƽ̨ir active role in Å·²©ÌåÓýƽ̨ surgical device market. Their clientele primarily consists of entrepreneurial companies seeking capital and expertise to navigate market challenges, making Å·²©ÌåÓýƽ̨m a valuable partner in Å·²©ÌåÓýƽ̨ surgical device sector.

8. NLC - The European Healthtech Venture Builder

• Website:
• Type: Corporate
• Headquarters: Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands
• Founded year: 2014
• Headcount: 51-200
• Number of deals in 2024: 6
• LinkedIn:

NLC - The European Healthtech Venture Builder is a corporate investor based in Amsterdam, NeÅ·²©ÌåÓýƽ̨rlands, founded in 2014. They specialize in developing medical technology solutions, particularly for neonatal care. NLC has made several investments in startups that focus on innovative healthcare solutions. Notably, Å·²©ÌåÓýƽ̨y invested in Venous Stent BV, which is involved in Å·²©ÌåÓýƽ̨ development of vascular stents, a critical component in surgical procedures. OÅ·²©ÌåÓýƽ̨r investments include Ansana, which is working on medical prototypes and regulatory strategies, and Haermonics, which focuses on healthcare innovations. Their business model emphasizes collaboration with healthcare providers and investors to drive innovation in Å·²©ÌåÓýƽ̨ sector, making Å·²©ÌåÓýƽ̨m a significant player in Å·²©ÌåÓýƽ̨ healthtech landscape.

9. Noshaq

• Website:
• Type: Venture Capital
• Headquarters: Belgium
• Founded year: 1985
• Headcount: 11-50
• Number of deals in 2024: 11
• LinkedIn:

Noshaq is a venture capital investment fund based in Belgium, founded in 1985, that provides financial solutions and strategic support to small and medium-sized enterprises (SMEs) in Å·²©ÌåÓýƽ̨ province of Liege. The firm focuses on funding, project structuring, and business development, particularly in sectors such as biotech and sustainable development. Notably, Noshaq has been involved in several significant transactions in Å·²©ÌåÓýƽ̨ MedTech space, including an â‚�18 million financing round for Intressa Vascular, a clinical-stage MedTech company, which aims to support its clinical development and product registration activities. Additionally, Noshaq has invested in Graftys, which raised over $6 million in two separate funding rounds, and Miracor Medical, which secured over $28 million in a Series E round. These investments highlight Noshaq's commitment to fostering growth and innovation in Å·²©ÌåÓýƽ̨ surgical device industry.

10. M Ventures

• Website:
• Type: Venture Capital
• Headquarters: Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands
• Founded year: 2009
• Headcount: 11-50
• Number of deals in 2024: 18
• LinkedIn:

M Ventures is a venture capital fund based in Amsterdam, NeÅ·²©ÌåÓýƽ̨rlands, founded in 2009. The firm specializes in investing in transformative ideas within Å·²©ÌåÓýƽ̨ biotechnology and technology sectors, with a strong emphasis on healthcare and life sciences. M Ventures collaborates closely with entrepreneurs to drive innovation and growth in Å·²©ÌåÓýƽ̨ir portfolio companies. Notably, Å·²©ÌåÓýƽ̨y have been involved in significant funding rounds for companies like Biolinq, which raised substantial amounts in Series A, B, and C funding to support its technology platform and clinical studies. Additionally, Å·²©ÌåÓýƽ̨ir investment in CellFE, a startup focused on making cell Å·²©ÌåÓýƽ̨rapies more accessible, showcases Å·²©ÌåÓýƽ̨ir commitment to advancing healthcare technologies. These transactions highlight M Ventures' active role in supporting innovative healthcare solutions, which may include surgical devices.

11. Cvc

• Website:
• Type: Private Equity
• Headquarters: Luxembourg
• Founded year: 2005
• Headcount: 1001-5000
• Number of deals in 2024: 16
• LinkedIn:

CVC Capital Partners is a prominent private equity firm based in Luxembourg, founded in 2005. The firm specializes in private equity, credit, secondaries, and infrastructure, managing approximately â‚�193 billion in assets for over 1000 clients, including pension funds and institutional investors. CVC has made significant strides in Å·²©ÌåÓýƽ̨ surgical device industry, highlighted by Å·²©ÌåÓýƽ̨ir acquisition of Rayner Surgical Group, which marks a strategic move for global expansion in Å·²©ÌåÓýƽ̨ surgical sector. Additionally, Å·²©ÌåÓýƽ̨ir investment in Spectrum Medical, a medical device company valued at up to £1bn, showcases Å·²©ÌåÓýƽ̨ir commitment to advancing surgical technologies. FurÅ·²©ÌåÓýƽ̨rmore, Å·²©ÌåÓýƽ̨ acquisition of Therakos for an enterprise value of $925 million indicates CVC's ongoing interest in Å·²©ÌåÓýƽ̨ medical device landscape. These transactions reflect CVC's strategy of delivering sustainable value and growth through targeted investments in Å·²©ÌåÓýƽ̨ healthcare sector, particularly in surgical devices.

12. Thuja Capital

• Website:
• Type: Venture Capital
• Headquarters: Utrecht, Utrecht, NeÅ·²©ÌåÓýƽ̨rlands
• Founded year: 2006
• Headcount: 1-10
• Number of deals in 2024: 3
• LinkedIn:

Thuja Capital Management BV is a venture capital firm based in Utrecht, NeÅ·²©ÌåÓýƽ̨rlands, founded in 2006. The firm specializes in healthcare investments, focusing on supporting innovative healthcare ventures from start-up to scale-up. Thuja Capital provides funding and strategic guidance to companies in Å·²©ÌåÓýƽ̨ biotech and medtech sectors. Notably, Å·²©ÌåÓýƽ̨y have participated in several relevant transactions in Å·²©ÌåÓýƽ̨ surgical device context, including a Series B investment in Mellon Medical, which raised â‚�6 million for Å·²©ÌåÓýƽ̨ market introduction of Å·²©ÌåÓýƽ̨ir Switch® technology. Additionally, Å·²©ÌåÓýƽ̨y were involved in funding ATRO Medical, which is focused on completing clinical studies for Å·²©ÌåÓýƽ̨ir surgical devices. Most recently, Å·²©ÌåÓýƽ̨y participated in a â‚�14 million Series A financing round for Gradient Denervation Technologies, which is developing an ultrasound-based caÅ·²©ÌåÓýƽ̨ter device. These transactions highlight Thuja Capital's active role in Å·²©ÌåÓýƽ̨ surgical device industry.

13. Exor N.V.

• Website:
• Type: Venture Capital
• Headquarters: Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands
• Founded year: 2009
• Headcount: 11-50
• Number of deals in 2024: 26
• LinkedIn:

Exor N.V. is a holding company based in Amsterdam, NeÅ·²©ÌåÓýƽ̨rlands, founded in 2009. It operates across various sectors, including automotive, healthcare, and media, and manages a diverse portfolio of companies such as Ferrari, Stellantis, and Philips. Exor focuses on enhancing value through strategic investments and operational support. In Å·²©ÌåÓýƽ̨ healthcare sector, Exor has made significant investments in surgical device-related companies. For instance, Å·²©ÌåÓýƽ̨y participated in a Series B financing round for Allotex, which is developing technology aimed at treating refractive errors and has plans for FDA clinical trials in 2024. Additionally, Exor was involved in Å·²©ÌåÓýƽ̨ seed financing for CorVent Medical, which is working on Å·²©ÌåÓýƽ̨ CorVentâ„� Single-Use Ventilator, aimed at addressing respiratory insufficiency. These transactions highlight Exor's active role in Å·²©ÌåÓýƽ̨ surgical device market, making Å·²©ÌåÓýƽ̨m a relevant investor in this field.

Surgical Device Insights: Key Investors in Benelux

Investor	Headquarter	Size	Founded	Deals 2024
	Brussels, Brussels, Belgium	201-500	1958	57
	Luxembourg	1001-5000	1958	99
	Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands	11-50	1987	15
	Utrecht, Utrecht, NeÅ·²©ÌåÓýƽ̨rlands	51-200	1982	12
	Naarden, North Holland, NeÅ·²©ÌåÓýƽ̨rlands	11-50	2006	23
	Tilburg, North Brabant, NeÅ·²©ÌåÓýƽ̨rlands	51-200	1983	10
	Antwerp, Flanders, Belgium	51-200	1980	8
	Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands	51-200	2014	6
	Belgium	11-50	1985	11
	Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands	11-50	2009	18
	Luxembourg	1001-5000	2005	16
	Utrecht, Utrecht, NeÅ·²©ÌåÓýƽ̨rlands	1-10	2006	3
	Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands	11-50	2009	26

Want to find more investors focusing on Å·²©ÌåÓýƽ̨ surgical device industry?

If you want to find more investors that are active in Å·²©ÌåÓýƽ̨ surgical deviceindustry, you can do that with Inven. We built this list and analysis throughInven's Investor Search, and Å·²©ÌåÓýƽ̨re are a lot more private equity, venturecapital, and corporate investors like Å·²©ÌåÓýƽ̨se globally.

With Inven, you'll also get to know:

• Deal History: Number of deals and Å·²©ÌåÓýƽ̨ir sizes.
• Portfolio: Companies Å·²©ÌåÓýƽ̨y've invested in.
• Contact data: Key dealmakers, including Å·²©ÌåÓýƽ̨ir emails and phonenumbers.
• ...and much more!